TBX1 and chordoma: Notably, both patients who achieved impressive clinical improvement were treated with ICIs prior to the use of MVA-brachyury-TRICOM vaccine [45], suggesting that the brachyury vaccine combined with ICIs may prove to be a potential regimen for chordoma patients.